Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Journal of Colloid and Interface Science
|
May 19, 2026
PEG-lipid structure controls in vitro PEG shedding, surface remodeling, and timing of lipid nanoparticle-mediated silencing
Teresa Ferrillo, Federica Santoro, Paola De Cicco, et al.
Expert Opinion on Therapeutic Targets
|
July 10, 2015
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors
Rosamaria Pinto, Sabino Strippoli, Simona De Summa, et al.
Melanoma Research
|
August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup
Ruggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Therapeutic Advances in Medical Oncology
|
December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
Maristella Saponara, Laura Pala, Fabio Conforti, et al.
Frontiers in Oncology
|
December 31, 2020
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm
Antonella Argentiero, Antonio Giovanni Solimando, Valentina Ungaro, et al.
Oncotarget
|
October 25, 2016
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family
Simona De Summa, Michele Guida, Stefania Tommasi, et al.
Plos One
|
December 2, 2014
Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation
Vito Michele Garrisi, Sabino Strippoli, Simona De Summa, et al.
Experimental Cell Research
|
January 4, 2014
Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Amalia Azzariti, Letizia Porcelli, Anita Mangia, et al.
Acta Dermato-Venereologica
|
September 19, 2019
Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
Alice Ramondetta, Simone Ribero, Luca Conti, et al.
Frontiers in Immunology
|
August 18, 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study
Simona De Summa, Giuseppe De Palma, Veronica Ghini, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Journal of Colloid and Interface Science
|
May 19, 2026
PEG-lipid structure controls in vitro PEG shedding, surface remodeling, and timing of lipid nanoparticle-mediated silencing
Teresa Ferrillo, Federica Santoro, Paola De Cicco, et al.
Expert Opinion on Therapeutic Targets
|
July 10, 2015
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors
Rosamaria Pinto, Sabino Strippoli, Simona De Summa, et al.
Melanoma Research
|
August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup
Ruggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Therapeutic Advances in Medical Oncology
|
December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
Maristella Saponara, Laura Pala, Fabio Conforti, et al.
Frontiers in Oncology
|
December 31, 2020
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm
Antonella Argentiero, Antonio Giovanni Solimando, Valentina Ungaro, et al.
Oncotarget
|
October 25, 2016
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family
Simona De Summa, Michele Guida, Stefania Tommasi, et al.
Plos One
|
December 2, 2014
Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation
Vito Michele Garrisi, Sabino Strippoli, Simona De Summa, et al.
Experimental Cell Research
|
January 4, 2014
Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Amalia Azzariti, Letizia Porcelli, Anita Mangia, et al.
Acta Dermato-Venereologica
|
September 19, 2019
Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
Alice Ramondetta, Simone Ribero, Luca Conti, et al.
Frontiers in Immunology
|
August 18, 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study
Simona De Summa, Giuseppe De Palma, Veronica Ghini, et al.
Page
of 13